Multienzyme‐Mimicking Nanocomposite for Tumor Phototheranostics and Normal Cell Protection
Source abstract
Abstract
Abstract Selectively regulating the reactive oxygen species (ROS) level in cells by redox modulation with nanoparticles mimicking multiple enzymes holds great promise for protecting normal cells against ROS threats and surpassing the current limitations of ROS‐dependent cancer therapy. Herein, we develop a new indocyanine green (ICG)‐bovine serum albumin (BSA)‐cerium‐manganese oxide nanocomposites (IBCM NCs) via facile one‐step biomineralization to functionally mimic superoxide dismutase and catalase. IBCM NCs can synergistically regulate superoxide, hydrogen peroxide, oxygen and glutathione levels in cancer cells as well as provide contrast for magnetic resonance imaging. Consequently, cancer hypoxia can be relieved, and the phototherapy efficiency can be dramatically enhanced, leading to a complete ablation of tumor under NIR laser irradiation. On the other hand, IBCM NCs can consume the superoxide and hydrogen peroxide in the normal cells to protect them against ROS threats. Our results demonstrate IBCM NCs can effectively resist ROS threats in normal cells and kill cancer cells through breaking the intracellular redox balance.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin 130022 P. R. China
University of Science and Technology of China Hefei Anhui 230026 P.R. China
The Departement of Radiology China-Japan Union Hospital of Jilin University Changchun Jilin 130022 China
Funding
National Natural Science Foundation of China
References (44)
Show source-provided references
1.
2. 10.1002/adma.20120065010.1002/adma.201200650 ↗
3. 10.1002/adma.20150022910.1002/adma.201500229 ↗
4.
5. 10.1016/j.biomaterials.2011.08.08610.1016/j.biomaterials.2011.08.086 ↗
6. 10.1002/anie.20121035910.1002/anie.201210359 ↗
7. 10.1002/ange.20121035910.1002/ange.201210359 ↗
8. 10.1038/nrd280310.1038/nrd2803 ↗
9. 10.1002/anie.20160550910.1002/anie.201605509 ↗
10. 10.1002/ange.20160550910.1002/ange.201605509 ↗
11.
12. 10.1002/adfm.20160425810.1002/adfm.201604258 ↗
13. 10.1002/smll.20160168110.1002/smll.201601681 ↗
14. 10.1002/anie.20151074810.1002/anie.201510748 ↗
15. 10.1002/ange.20151074810.1002/ange.201510748 ↗
16.
17. 10.1039/c0nr00875c10.1039/c0nr00875c ↗
18. 10.1016/j.molcel.2012.09.02510.1016/j.molcel.2012.09.025 ↗
19. 10.1016/0736-5748(95)00071-210.1016/0736-5748(95)00071-2 ↗
20. 10.1016/0891-5849(94)90079-510.1016/0891-5849(94)90079-5 ↗
21. 10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025 ↗
22.
23. 10.1021/acsami.5b0127110.1021/acsami.5b01271 ↗
24. 10.1021/acs.chemmater.7b0241210.1021/acs.chemmater.7b02412 ↗
25.
26. 10.1021/nn302024t10.1021/nn302024t ↗
27. 10.1002/adma.20140091410.1002/adma.201400914 ↗
28. 10.1021/nn402199g10.1021/nn402199g ↗
29. 10.1002/adma.20160003810.1002/adma.201600038 ↗
30. 10.1096/fj.10-15584610.1096/fj.10-155846 ↗
31. 10.1002/adfm.20170062610.1002/adfm.201700626 ↗
32. 10.1021/nn506238610.1021/nn5062386 ↗
33.
34. 10.1002/smll.20140222210.1002/smll.201402222 ↗
35. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
36. 10.1039/b615134e10.1039/b615134e ↗
37. 10.1016/j.cbi.2005.12.00910.1016/j.cbi.2005.12.009 ↗
38. 10.1002/adma.20160190210.1002/adma.201601902 ↗
39.
40. 10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025 ↗
41. 10.1016/j.pupt.2009.07.00410.1016/j.pupt.2009.07.004 ↗
42. 10.1021/jacs.7b1111410.1021/jacs.7b11114 ↗
43. 10.1002/anie.20151003110.1002/anie.201510031 ↗
44. 10.1002/ange.20151003110.1002/ange.201510031 ↗